Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2006
09/21/2006US20060211607 Somatostatin-dopamine chimeric analogs
09/21/2006US20060210898 Charge transport materials having at least a 1,3,6,8-tetraoxo-1,3,6,8-tetrahydrobenzo[lmn][3,8]phenanthroline-2,7-diyl group
09/21/2006CA2600860A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
09/21/2006CA2600521A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations
09/21/2006CA2599925A1 Cgrp receptor antagonists
09/21/2006CA2599643A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
09/21/2006CA2598695A1 Hydroxyalkyl substituted imidazoquinolines
09/20/2006EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1701959A1 Triazole derivatives as vasopressin antagonists
09/20/2006EP1701956A1 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/20/2006EP1701955A1 Arylalkenyl and arylalkynyl substituted imidazoquinolines
09/20/2006EP1701724A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/20/2006EP1599473B1 Imidazo 4,5-b quinoline-derivatives and their use as no-synthase inhibitors
09/20/2006EP1509491B1 Intermediate products, methods for their preparation and use thereof
09/20/2006EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1343780B1 Piperazine derivatives for treatment of bacterial infections
09/20/2006EP1073648B1 12,13-modified epothilone derivatives
09/20/2006EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives
09/20/2006CN1835951A Isethionate salt of a selective CDK4 inhibitor
09/20/2006CN1835950A Imidazopyridine derivatives
09/20/2006CN1835944A Quinolyl amide derivatives as CCR-5 antagonists
09/20/2006CN1835750A Oxime substituted imidazo-containing compounds
09/20/2006CN1835749A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/20/2006CN1834090A Benzimidazole compounds, its prepn. and uses
09/20/2006CN1276530C Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt
09/20/2006CN1275979C Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof
09/20/2006CN1275966C Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives
09/20/2006CN1275965C Derivatives of variolin b
09/20/2006CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
09/20/2006CN1275963C Process for production of naphthyridine-3-carboxylic acid derivatives
09/19/2006US7109377 Synthesis of combinatorial libraries of compounds reminiscent of natural products
09/19/2006US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands
09/19/2006US7109340 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use
09/19/2006US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
09/19/2006US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections.
09/19/2006US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects
09/19/2006US7109228 Pyrazole derivatives
09/19/2006US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
09/19/2006US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors
09/19/2006US7109209 Pyrazolopyridines, process for their preparation and use as therapeutic compounds
09/19/2006US7109208 Rho kinase inhibitors having axon of the retinal ganglion cellal extension- and optic nerve cell regeneration- promoting action, particularly (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide
09/19/2006US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes
09/19/2006US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions
09/19/2006US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
09/19/2006US7109192 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity
09/19/2006US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer
09/19/2006US7108847 Delivery of muscle relaxants through an inhalation route
09/19/2006CA2232195C Isoxazolidine derivatives
09/14/2006WO2006096053A1 A method of preparing a porphyrin derivative, a porphyrin derivative, use of said porphyrin
09/14/2006WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient
09/14/2006WO2006095268A1 Crystal forms of an imidazole derivative
09/14/2006WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors
09/14/2006WO2006094600A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
09/14/2006WO2006040113A3 Heterocyclic diamide insecticidal agents
09/14/2006US20060205948 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders
09/14/2006US20060205938 Monohydrate solvates of loracarbef
09/14/2006US20060205765 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents
09/14/2006US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
09/14/2006US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
09/14/2006US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine
09/14/2006US20060205744 Fused heterocyclic derivatives as ppar modulators
09/14/2006US20060205742 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
09/14/2006US20060205720 such as 2-(4-chloro-phenyl)-5-cyclopentyl-1-(2-fluoro-phenyl)-5,6-dihydro-1H-pyrrolo[3,4-d]imidazol-4-one; for treatment of eating disorders and psychological disorders
09/14/2006US20060205717 For combating phytopathogenic diseases on plants and harvested food crops; pyrido(2,3-B)pyrazine and pyrido pyridazine derivatives; volatile enough to be active in the vapour phase
09/14/2006US20060205710 Spiroazacyclic compounds as monoamine receptor modulators
09/14/2006US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
09/14/2006US20060204875 N-Substituted with groups including glycidyloxy-, glycidyloxyethyl-, acryloyloxy-, 1-phenylethyl-, and 2-ethyl-6-methylphenyl-; organophotoreceptors
09/14/2006US20060204437 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
09/14/2006DE102005011058A1 Substituierte Tetrahydro-pyrrolo-chinolinderivate Substituted tetrahydro-pyrrolo-quinoline derivatives
09/14/2006CA2600630A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
09/13/2006EP1700850A1 Novel phenylalanine derivative
09/13/2006EP1699792A1 Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds
09/13/2006EP1699791A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
09/13/2006EP1699790A2 Soluble polymers as amine capture agents and methods
09/13/2006EP1699789A2 Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate
09/13/2006EP1699788A2 Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
09/13/2006EP1699781A1 1-acetic acid-indole, -indazole and -benzimidazole derivatives useful for the treatment of respiratory disorders
09/13/2006EP1699780A1 Novel quinoline derivatives
09/13/2006EP1699767A2 Process for the preparation of pyridopyrimidones
09/13/2006EP1699761A1 Cb1 modulator compounds
09/13/2006EP1699454A1 Pyrazole derivatives and use thereof as orexin receptor antagonists
09/13/2006EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3
09/13/2006EP1511752B1 Camptothecins with a modified lactone ring
09/13/2006EP1483257B1 Quinazoline compounds useful in therapy
09/13/2006EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
09/13/2006EP0917462B1 Cell adhesion inhibitors
09/13/2006CN1833470A Compound, charge transporting material and organic electroluminescent element
09/13/2006CN1832761A Thiotungstate analogues and uses thereof
09/13/2006CN1830978A Pyrazolo [4,3c]-quinolin-3-one compound, prepn. method and use thereof
09/13/2006CN1274694C Lanthanum amino acid complex and its preparing process and application
09/13/2006CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient
09/13/2006CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound
09/12/2006US7105682 Substituted amine derivatives and methods of use
09/12/2006US7105677 Processes for the preparation of antiviral 7-azaindole derivatives
09/12/2006US7105676 Tetrahydropyridoethers
09/12/2006US7105674 A pigment preparation comprising at least one organic perylene pigment, and at least one perylene derivative, one or more rosins
09/12/2006US7105667 Fused heterocyclic compounds and use thereof
09/12/2006US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one
09/12/2006US7105562 2-methyl-6-[2-oxo-1,2-dihydro-indol-(3Z)-ylidene]1,4,5,6-tetrahydro-cyclopenta[b]pyrrole-3-carboxylic acid ethyl ester; disorders related to abnormal PK activity;
09/12/2006US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade